Islamabad Ban on Pregabalin Sale Without Prescription
In practice, the Pharmacy Services and Drug Control, Health Department Islamabad has reiterated the ban on the sale of pregabalin-containing medicines without a valid prescription, directing pharmacies and pharmacists to strictly comply with the regulations.
In practice, the Pharmacy Services and Drug Control, Health Department Islamabad has reiterated the ban on the sale of pregabalin-containing medicines without a valid prescription, directing pharmacies and pharmacists to strictly comply with the regulations.
Article outline
- What happened
- Reaction
- The bottom line
Key points
- Scientists Discover 31 New Genetic Regions Linked to Fatty Liver Disease.
- All licensed pharmacies and pharmacists have been directed to dispense pregabalin-containing medicines only against valid prescriptions.
- The department stressed that compliance with the directive was essential to protect public health and promote the safe employ of medicines.
- It additionally called on the public to consult qualified medical practitioners before obtaining prescription medicines and to follow medical advice to ensure their safe employ.
According to a public and pharmacists' alert issued by the Pharmacy Services and Drug Control section, the restriction is being enforced in line with directions issued on July 10, 2026. Scientists Discover 31 New Genetic Regions Linked to Fatty Liver Disease.
Meanwhile, the department stressed that compliance with the directive was essential to protect public health and promote the safe employ of medicines.
It additionally called on the public to consult qualified medical practitioners before obtaining prescription medicines and to follow medical advice to ensure their safe employ. Stay Connected with ProPakistani. Obtain the latest news and stories wherever you prefer. Follow on Google Discover. Follow on Google News Join WhatsApp. See more ProPakistani stories in Google Search and Top Stories.
In short, islamabad Ban on Pregabalin Sale Without Prescription is the central thread here, and readers can expect follow-up reporting as the picture becomes clearer.




